lung
diseas
common
patient
hematolog
neoplasm
vari
function
underli
diseas
treatment
lung
involv
associ
high
morbid
mortal
requir
earli
appropri
treatment
chest
comput
tomographi
ct
analysi
biolog
specimen
first
line
diagnost
tool
patient
sometim
invas
method
necessari
interpret
imag
requir
analysi
clinic
context
often
complex
start
knowledg
differenti
diagnosi
lung
find
radiologist
acquir
train
articl
aim
explain
key
clinic
radiolog
aspect
make
possibl
orient
diagnosi
correctli
understand
current
role
ct
treatment
strategi
group
patient
neoplasia
trasplant
de
precursor
resumen
la
pulmonar
en
la
historia
de
un
pacient
con
neoplasia
es
muy
frecuent
variabl
en
de
la
enfermedad
de
base
la
terapia
recibida
la
morbimortalidad
asociada
es
alta
por
lo
que
requier
un
tratamiento
correcto
precoz
la
computarizada
tc
junto
con
el
de
muestra
son
la
pleas
cite
articl
calvillo
p
carrer
polo
j
sanz
cabal
j
salavert
compt
torrero
l
neoplasia
de
lo
hallazgo
pulmonar
en
la
computarizada
p
calvillo
et
al
computarizada
multidetector
enfermedad
pulmonar
herramienta
de
de
primera
empleada
en
esto
pacient
en
determinado
caso
se
requieren
invasivo
la
de
la
exig
el
de
un
contexto
en
mucha
ocasion
complejo
partiendo
del
conocimiento
que
adquier
el
en
su
sobr
el
diferenci
de
lo
hallazgo
pulmonar
el
objetivo
de
est
trabajo
es
explicar
lo
aspecto
clave
que
permiten
orientar
correctament
el
asimilar
el
papel
actual
de
la
tc
en
la
estrategia
de
est
grupo
de
enfermo
hematolog
neoplasm
hn
character
frequent
dissemin
moment
diagnosi
bone
marrow
affect
especi
sensit
chemotherapi
radiotherapi
therefor
patient
usual
receiv
aggress
chemotherapi
certain
case
hematopoiet
precursor
transplant
hpt
diseas
per
se
treatment
caus
prolong
pancytopenia
predispos
seriou
infect
make
diagnost
therapeut
emerg
noninfecti
pulmonari
complic
secondari
treatment
also
frequent
determin
prognosi
pulmonari
tumor
diseas
includ
infiltr
due
hn
pulmonari
neoplasm
posthpt
lymphoma
chest
comput
tomographi
ct
narrow
differenti
diagnosi
diseas
indic
review
well
main
clinic
inform
record
radiolog
applic
interpret
find
base
clinic
context
perform
helic
chest
ct
patient
hn
pursu
two
object
earli
detect
lesion
visibl
chest
xray
requir
urgent
treatment
better
character
find
outlin
diagnost
therapeut
possibl
reconstruct
mm
cut
thick
high
resolut
comput
tomographi
hrct
requir
sinc
mani
pulmonari
complic
kick
interstiti
pattern
etiolog
diagnosi
fever
manifest
patient
neutropenia
andor
hpt
requir
search
microorgan
infecti
marker
chest
hrct
play
fundament
role
urgent
clinic
sign
sever
earli
h
absenc
respons
antibiot
therapi
h
treatment
possibl
invas
fungal
infect
ifi
requir
earli
administr
determin
factor
prognosi
patient
clinic
classifi
high
risk
ifi
antifung
drug
administ
empir
subgroup
lower
risk
possibl
delay
treatment
case
like
clinic
manifest
earli
posit
specif
infect
marker
reduc
high
cost
toxic
drug
marker
usual
use
serum
galactomannan
test
chest
hrct
perform
earli
serial
way
galactomannan
compon
aspergillu
cell
membran
fall
disus
marker
due
loss
sensit
associ
antifung
prophylaxi
hrct
gain
import
still
urgent
diagnost
test
allow
start
earli
therapi
pulmonari
lesion
characterist
ifi
visual
addit
give
rise
etiolog
guid
acquisit
bronchoalveolar
lavag
bal
bronchoscopi
thu
speed
diagnosi
germ
cover
initi
empir
therapi
respiratori
manifest
hrct
necessari
identifi
character
noninfecti
complic
relaps
secondari
neoplasm
go
unnot
radiograph
test
show
similar
pattern
studi
hrct
patient
hn
need
know
clinic
inform
fundament
data
underli
condit
well
therapi
complic
tabl
patient
hodgkin
lymphoma
hl
nonhodgkin
lymphoma
nhl
receiv
less
intens
polychemotherapi
leukemia
shorter
neutropenia
pulmonari
lesion
seen
possibl
tumor
affect
taken
consider
odd
find
pulmonari
neoplast
spread
autopsi
leukemia
radiolog
manifest
except
respiratori
diseas
mainli
mark
infect
acut
myeloid
leukemia
aml
deserv
special
attent
sinc
pulmonari
manifest
occur
stage
diseas
possibl
observ
ad
infect
case
hemorrhag
due
thrombocytopenia
toxic
due
chemotherapi
multipl
myeloma
mm
occur
mainli
bacteri
infect
due
humor
immun
defici
hypoventil
due
bone
affect
pulmonari
edema
common
find
pulmonari
infiltr
due
amyloid
plasma
cell
light
chain
deposit
rare
chemotherapeut
drug
depress
immun
function
respons
pulmonari
toxic
suspect
radiolog
pattern
tempor
relat
treatment
therapeut
agent
use
caus
respiratori
failur
often
radiolog
express
similar
alveolar
damag
edema
hemorrhag
especi
chemosensit
tumor
lymphoma
mm
goal
autolog
hpt
allow
administr
high
dose
chemotherapi
subsequ
corticotherapi
graft
vs
host
diseas
gvhd
immunosuppress
therapi
actual
infecti
prophylaxi
widespectrum
antibiot
antifung
prophylaxi
p
jirovecii
rescu
hematopoiesi
thank
infus
hematopoiet
precursor
obtain
previous
patient
prevent
irrevers
medullari
failur
shorten
time
neutropenia
pulmonari
complic
fundament
consequ
intens
chemotherapi
consequ
transplant
per
se
allogen
hpt
mainli
use
patient
acut
leukemia
reestablish
hematopoiet
immun
function
cell
obtain
famili
member
ident
hla
human
leukocyt
antigen
els
someon
unrel
compat
hla
may
come
bone
marrow
peripher
blood
umbil
cord
transplant
patient
receiv
condit
high
dose
chemotherapi
without
fullbodi
radiotherapi
suppress
bone
marrow
destroy
malign
cell
prevent
host
reject
graft
cell
also
strong
immunosuppress
treatment
later
administ
avoid
revers
reject
hematopoiet
function
reinstat
donor
cell
recogn
recipi
tissu
foreign
caus
graftversushost
diseas
gvhd
yet
despit
patient
develop
gvhd
requir
extend
immunosuppress
therapi
explain
allogen
hpt
recipi
suffer
deep
prolong
immun
deficit
lead
death
nearli
patient
base
specif
moment
histori
patient
includ
one
group
approach
diagnosi
tabl
see
tabl
onset
diseas
treatment
infecti
node
uncommon
usual
bacteri
viral
except
moment
diagnosi
aml
sever
cytopenia
iron
overload
fungal
sever
immunolog
depress
patient
node
fungal
viral
bacteri
fig
filament
fungi
common
prolong
deep
neutropenia
two
week
especi
chemotherapi
aml
earli
posthpt
period
invas
aspergillosi
possibl
observ
node
usual
multiplebilater
least
one
cm
groundglass
attenu
halo
distinguish
bacteri
node
usual
disappear
first
five
day
mucormycosi
suspect
aspergillosi
node
observ
well
sinu
affect
pleural
effus
andor
invert
halo
sign
especi
antifung
therapi
cover
fungu
hrct
use
serolog
test
avail
today
diagnosi
mucormycosi
viral
node
often
poorlydefin
edg
andor
halo
distinguish
small
size
cm
absenc
cavit
bacteri
node
usual
betterdefin
edg
centrilobular
node
often
repres
unspecif
infecti
bronchiol
especi
accompani
sproutingtre
imag
howev
diffus
symmetr
bilater
centrilobular
node
predomin
upper
field
groundglass
attenu
absenc
infecti
find
lead
respiratori
bronchiol
tobacco
pneumon
due
hypersensit
secondari
treatment
nhl
hl
infiltr
observ
often
relaps
increas
due
greater
surviv
patient
current
therapi
usual
manifest
multipl
pulmonari
node
cm
irregular
edg
consolid
andor
mass
frequent
nhl
wors
prognosi
primari
pulmonari
lymphoma
occur
patient
year
age
usual
nonhodgkin
b
malt
type
mucosaassoci
lymphoid
tissu
show
nodul
peribronchovascular
consolid
bronchogram
test
lesion
singl
multipl
bilater
character
absenc
mediastin
adenopathi
moment
diagnosi
month
later
grow
slowli
ident
present
lymphocyt
interstiti
pneumonia
also
describ
fig
myeloid
leukemia
myelodysplast
syndrom
make
blastic
tumor
call
granulocyt
sarcoma
extrem
rare
lung
occur
node
mass
consolid
except
mm
present
node
andor
mass
associ
adenopathi
simul
lymphoma
pulmonari
cancer
bad
prognosi
lymphomatoid
granulomatosi
extranod
lymphoprolif
process
associ
epstein
barr
viru
ebv
mainli
affect
lung
central
nervou
system
occur
multipl
pulmonari
node
case
variabl
number
size
basal
predomin
node
progress
rapidli
coalesc
cavit
well
disappear
spontan
migrat
evolv
make
sign
invert
halo
sign
secondari
neoplasm
lung
cancer
increas
survivor
hl
nhl
cll
etiopathogenesi
studi
appear
rang
one
sever
year
diagnosi
hn
patient
receiv
allogen
hpt
develop
posttranspl
lymphoprolif
disord
ptld
usual
first
six
month
year
second
peak
year
ptld
hivassoci
lymphoma
attribut
ebv
pulmonari
node
usual
bilater
welldefin
may
associ
halo
import
take
ifi
take
account
clinic
context
evolut
lesion
ifi
node
typic
cavit
week
diseas
onset
accompani
recoveri
neutropenia
neutrophil
make
grow
air
imag
crescent
moon
previous
node
show
low
central
attenu
fig
low
attenu
node
invas
fungal
infect
ifi
due
aspergillu
acut
lymphoid
leukemia
prolongu
neutropenia
highresolut
comput
tomographi
ct
upper
cut
upper
side
imag
lower
cut
lower
side
imag
node
low
attenu
seen
imag
filter
mediastin
window
arrow
typic
ifi
due
necrosi
prior
cavit
seen
two
week
later
c
f
serum
gactolamannan
posit
one
month
later
fungal
bacteri
consolid
especi
staphylococc
tubercul
one
also
cavit
less
commonli
node
consolid
due
lymphoma
appear
cavit
node
correspond
langerhan
cell
histiocytosi
describ
patient
hl
rare
leukemia
known
whether
actual
associ
case
tobacco
play
role
etiopathogenesi
area
attenu
groud
glass
consolid
fig
see
tabl
infect
diseas
onset
cours
mm
possibl
observ
bacteri
viral
bronchopneumonia
similar
rest
popul
patient
sever
immunodepress
due
differ
germ
see
tabl
segment
lobar
consolid
often
bacteri
ifi
suspect
pleural
base
halo
sensit
diagnost
sign
vascular
occlus
sinu
lesion
shown
pulmonari
angioct
patch
bilater
groundglass
opac
whose
size
variabl
typic
virus
accompani
small
node
consolid
patient
hpt
pave
pattern
viral
origin
mainli
less
commonli
noninfecti
caus
infect
due
pneumocysti
jirovecii
caus
perihilar
bilater
groundglass
attenu
area
upper
field
usual
day
posthpt
moment
prophylaxi
usual
withdrawn
respiratori
colon
due
candida
common
patient
pneumonia
except
except
situat
spread
candidiasi
emerg
noncandida
yeast
caus
infecti
pulmonari
consolid
node
pulmonari
edema
frequent
cours
mm
due
pet
cardiac
andor
renal
amyloidosi
aml
mainli
consequ
treatment
onset
cours
aml
differenti
diffus
alveolar
hemorrhag
dah
due
thrombocytopenia
andor
infect
secondari
pulmonari
lymphoid
infiltr
leukemia
rare
seen
groundglass
attenu
area
consolid
similar
organ
pneumonia
adenopathi
patient
cll
year
evolut
adenopathi
appear
peribronchovascular
consolid
even
endobronchi
occup
clinic
worsen
make
us
suspect
transform
highgrad
lymphoma
leukostasi
aggreg
blast
pulmonari
microvascular
except
suspect
diagnosi
relaps
aml
due
rapid
increas
percentag
leucocyt
blood
character
respiratori
neurolog
failur
kick
con
pulmonari
consolid
partli
due
alveolar
damag
hemorrhag
due
plateletpenia
mm
consolid
due
pulmonari
infiltr
plasmat
cell
caus
respiratori
distress
poor
prognosi
also
describ
noninfecti
complic
secondari
treatment
h
follow
transfus
blood
product
sudden
appear
consolid
simul
edema
accompani
respiratori
failur
usual
reflect
acut
pulmonari
damag
apd
call
trali
transfusionrel
alveolar
lung
injuri
associ
high
mortal
rate
cours
chemotherapi
caus
pulmonari
toxic
although
usual
pattern
organ
pneumonia
op
unspecif
interstiti
pneumonia
uip
pneumon
due
hypersensit
eosinophil
pneumonia
diffus
alveolar
damag
carmustin
use
lymphoma
mm
usual
give
uip
pattern
cytarabin
administ
high
dose
treatment
aml
caus
noncardiogen
pulmonari
edema
bleomycin
lymphoma
treatment
caus
diffus
alveolar
damag
op
among
common
drug
use
expir
beforehpt
rituximab
monoclon
antibodi
use
treatment
lymphoprolif
b
syndrom
associ
pulmonari
diseas
due
mechan
clarifi
yet
median
four
cycl
median
time
appear
week
last
infus
groundglass
area
bilater
diffus
pulmonari
consolid
appear
week
month
less
commonli
hour
day
correspond
histolog
inflammatori
lymphocyt
infiltr
among
other
show
hypoxemia
lethal
evolut
granulocyt
colonystimul
factor
gcsf
use
neutropenia
recoveri
rare
induc
apd
first
day
treatment
display
imag
similar
edema
alveolar
hemorrhag
alltran
retino
acid
atra
arsen
trioxid
use
treatment
acut
promyelocyt
leukemia
caus
differenti
syndrom
consist
respiratori
failur
manifest
follow
day
probabl
due
releas
cytokin
pleural
effus
groundglass
area
bronchial
wall
thicken
due
edema
hemorrhag
seen
pregraft
earli
posthpt
period
becom
complic
pulmonari
edemahydrostat
due
increas
patenc
common
noninfecti
complic
dah
multifactor
etiolog
character
larg
groundglass
attenu
area
evolv
pave
pattern
absenc
cardiomegalia
effus
hemoptysi
observ
case
drop
level
hemoglobin
high
rate
macrophag
bal
help
us
diagnosi
graft
syndrom
pregraft
respiratori
distress
consequ
endotheli
damag
possibl
due
releas
proinflammatori
cytokin
similar
edema
without
cardiomegalia
clinic
manifest
fever
cutan
exanthem
idiopath
pneumonia
syndrom
defin
american
thorac
societi
acut
respiratori
failur
diffus
alveolar
damag
absenc
cardiac
renal
diseas
iatrogenesi
respons
microorgan
exclus
diagnosi
probabl
multifactor
etiolog
due
nonaffili
infect
would
happen
recent
discov
metapneumoviru
late
posthpt
period
peribronchovascular
reticul
groundglass
area
occas
pave
pattern
one
repres
unclassifi
interstiti
pneumonia
associ
reject
histolog
correspond
bronchioloalveolar
lymphoplasmocyt
infiltr
spread
toward
peripher
region
evolv
fibrosi
traction
hive
bronchiectasi
op
secondari
infect
toxic
drug
radiotherapi
reject
peripher
peribronchovascular
perilobular
consolid
invert
halo
sign
characterist
find
appropri
clinic
context
situat
neutropenia
invert
halo
lead
us
consid
mucormycosi
first
place
differ
op
thick
ring
cm
also
present
intern
reticul
fig
acut
pneumon
due
radiat
occur
week
mediastin
lymphoma
radiotherapi
caus
clinic
radiolog
manifest
similar
pneumonia
locat
irradi
area
mark
delimit
healthi
parenchyma
evolv
paramediastin
fibrosi
acut
pulmonari
reject
hpt
pulmonari
alveolar
proteinosi
due
leukem
infiltr
late
treatment
extrem
rare
imag
repres
bronchiol
fill
mucou
liquid
pu
usual
correspond
infecti
bronchiol
due
mani
differ
germ
due
unspecif
respiratori
infect
smoke
bronchiol
obliteran
lymphoid
infiltr
bronchial
condit
liquid
retent
inflammatori
tumor
infiltr
perilymphat
distribut
translat
thicken
bronchovascular
axe
interlobular
septa
subpleur
interstic
straight
interstiti
thicken
correspond
interstiti
pulmonari
edema
graft
syndrom
earli
postgraft
period
month
follow
hpt
pulmonari
venoocclus
diseas
rare
complic
lead
pulmonari
hypertens
pulmonari
congest
absenc
left
cardiac
diseas
secondari
lymphat
tumor
pulmonari
infiltr
kick
straight
nodular
thicken
perilymphat
interstic
make
peribronchi
consolid
fig
case
dissemin
retrograd
hilar
mediastin
affect
get
occlud
airway
especi
cll
mm
pulmonari
amyloidosi
seen
radiolog
septal
interstiti
thicken
chest
comput
tomographi
ct
mild
mosaic
pattern
expir
due
air
entrap
asterisk
heart
failur
pleuropericardi
effus
due
cardiac
serou
amyloidosi
although
frequent
caus
pulmonari
carcinoma
forget
rare
form
hl
nhl
present
also
cours
cll
possibl
see
lymphoid
growth
lumen
bronchial
wall
make
obstruct
endolumin
mass
case
extraoss
plasmacytoma
endolumin
mass
publish
characterist
find
bronchiol
obliteran
bo
common
relev
complic
month
posthpt
consid
chronic
gvhd
defin
function
criteria
airway
obstruct
absenc
activ
respiratori
infect
confirm
transbronchi
andor
surgic
biopsi
bo
syndrom
diagnos
without
histolog
air
trap
andor
bronchiectasi
hrct
gvhd
least
one
organ
imag
forc
expir
show
air
entrap
case
hand
yet
despit
fact
find
diagnost
sensit
use
detect
earli
preclin
stage
bronchiectasi
appear
advanc
stage
progress
associ
forc
expiratori
volum
one
second
hrct
use
addit
rule
airway
infect
tumor
infiltr
alter
respiratori
test
diseas
caus
slow
function
worsen
especi
detect
earli
treatment
corticoid
immun
depress
caus
infecti
complic
main
caus
death
secondari
distress
toxic
infect
radiotherapi
fig
late
period
hpt
correspond
unclassifi
interstiti
pneumonia
pleuroparenchymat
fibroelastosi
like
consequ
chemotherapi
radiotherapi
gvhd
histori
distribut
evolut
find
guid
etiolog
diagnosi
seen
transitori
way
sinu
infecti
consolid
due
organ
pneumonia
irrevers
dilat
bronchiectasi
area
air
entrap
characterist
find
bronchiol
obliteran
unlik
observ
area
fibrosi
due
traction
interstiti
pulmonari
emphysema
air
leak
syndrom
fig
typic
complic
advanc
posthpt
bo
marker
poor
prognosi
increas
alveolar
pressur
lead
ruptur
air
leak
around
week
later
normal
evolut
mean
nonrespons
c
cavit
two
week
later
coincid
recov
neutropenia
air
crescent
sign
arrow
f
differ
patient
consolid
asterisk
initi
halo
two
week
later
e
size
increas
disappear
halo
size
decreas
persist
peribronchovascular
consolid
bronchial
dilat
f
without
resolut
resect
lesion
guarante
control
infect
hematopoiet
precursor
transplant
hpt
show
organ
pneumonia
without
microorgan
malign
cell
bronchovascular
axe
due
retrograd
dissect
reach
mediastinum
subcutan
tissu
pleural
caviti
treatment
usual
conserv
except
pneumothorax
requir
drainag
pulmonari
infiltr
radiotherapi
infect
postul
caus
greater
incid
pneumothorax
hodgkin
diseas
fig
absenc
radiotherapi
infect
possibl
pleurapulmonari
infiltr
describ
lymphoma
mm
taken
consider
late
posthpt
period
air
leak
syndrom
due
bo
ruptur
apic
vesicl
due
pleuroparenchymat
fibroelastosi
taken
consider
small
cyst
upper
field
correspond
pneumatocel
due
infect
pneumocysti
jirovecii
bilater
cyst
isol
associ
node
adenopathi
make
us
think
possibl
pulmonari
diseas
due
light
chain
deposit
diseas
patient
mm
macroglobulinemia
obstruct
function
pattern
fig
patient
fever
activ
infect
find
hrct
recommend
examin
repeat
resolut
find
case
good
clinic
respons
possibl
wait
sever
week
even
month
estim
time
resolut
find
first
week
treatment
ifi
lesion
grow
wors
mean
poor
evolut
fig
also
conveni
recogn
infect
immun
reconstruct
syndrom
taken
absenc
respons
inflammatori
exacerb
secondari
neutrophil
recoveri
withdraw
immunosuppress
therapi
turn
translat
clinic
worsen
lesion
growth
b
suspicion
good
respons
due
clinic
andor
radiograph
find
import
repeat
diagnost
test
rule
initi
unidentifi
mix
infect
node
detect
without
infecti
clinic
manifest
compar
previou
imag
find
whether
residu
infect
occur
period
immun
suppress
indetermin
node
follow
accord
recommend
made
fleischner
societi
fnpa
biopsi
consid
lesion
suspect
malign
characterist
due
histori
lymphoma
andor
allogen
hpt
lesion
evolv
expect
therapi
fig
preferenti
sampl
obtain
cutan
guid
ct
ultrasound
transbronchi
access
surgeri
consid
last
resort
prefer
videothoracoscopi
avail
diffus
pulmonari
diseas
unclear
etiolog
usual
end
requir
surgic
videothoracoscop
pulmonari
biopsi
due
greater
diagnost
yield
petct
use
stage
follow
metabolicallyact
lymphoma
also
patholog
uptak
absenc
pulmonari
find
hrct
rais
earli
suspicion
drug
toxic
leukem
infiltr
use
differenti
activ
lesion
scar
whether
toxic
infecti
tumor
patient
hp
thorac
hrct
help
us
come
close
differenti
diagnosi
infecti
noninfecti
pulmonari
complic
integr
imag
find
clinic
data
hrct
need
perform
case
acut
clinic
present
quickli
suspicion
ifi
allow
us
assess
respons
treatment
detect
malign
optim
obtent
bal
pulmonari
biopsi
protect
peopl
anim
author
declar
experi
human
be
anim
perform
conduct
investig
data
confidenti
author
declar
articl
data
patient
right
privaci
inform
consent
author
declar
articl
data
patient
author
declar
conflict
interest
